Cumberland pharmaceuticals reports first quarter 2024 financial results & company update

Nashville, tenn., may 7, 2024 /prnewswire/ -- cumberland pharmaceuticals inc. (nasdaq: cpix), a specialty pharmaceutical company, today announced that its product portfolio of fda-approved brands delivered combined revenues of $8.5 million during the first quarter of 2024.

CPIX Ratings Summary

CPIX Quant Ranking